+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

From
Smart Precision Medicine Software Market Report 2026 - Product Thumbnail Image

Smart Precision Medicine Software Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Artificial Intelligence in Oncology Market Report 2026 - Product Thumbnail Image

Artificial Intelligence in Oncology Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Precision Medicine Software Market Report 2026 - Product Thumbnail Image

Precision Medicine Software Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Osimertinib Mesylate Tablets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Osimertinib Mesylate Tablets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Gene Panel Market 2026-2030 - Product Thumbnail Image

Gene Panel Market 2026-2030

  • Report
  • February 2026
  • 295 Pages
  • Global
From
Kinase Drug Discovery Solutions Market Report 2026 - Product Thumbnail Image

Kinase Drug Discovery Solutions Market Report 2026

  • Report
  • March 2026
  • 250 Pages
  • Global
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more